Multisignal reagents for labeling analytes

US11073512B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11073512-B2
Application numberUS-201816202213-A
CountryUS
Kind codeB2
Filing dateNov 28, 2018
Priority dateApr 3, 2003
Publication dateJul 27, 2021
Grant dateJul 27, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The assay comprises: combining a sample suspected of containing the analyte with the above-described composition and a binding agent that binds to the analyte; and detecting the signal or the first member of the second binding pair that is bound to the binding agent. Additionally provided is a multisignal labeling reagent comprising a first polymer covalently bound to (a) a reactive group or a first member of a first binding pair, and (b) more than one digoxigenin molecule.

First claim

Opening claim text (preview).

What is claimed is: 1. A DNA oligonucleotide having a 5′ end and a 3′ end, comprising: a first member of a first binding pair attached at the 5′ end of the DNA oligonucleotide, wherein the first binding pair is an antigen-antibody binding pair; and a first member of a second binding pair attached at the 3′ end of the DNA oligonucleotide, wherein the second binding pair is an antigen-antibody binding pair. 2. The DNA oligonucleotide of claim 1 , wherein the first member of the first binding pair is a protein. 3. The DNA oligonucleotide of claim 2 , wherein the first member of the first binding pair is an antibody. 4. The DNA oligonucleotide of claim 1 , wherein the first member of the second binding pair is a protein. 5. The DNA oligonucleotide of claim 4 , wherein the first member of the second binding pair is an antibody. 6. The DNA oligonucleotide of claim 3 , wherein the first member of the second binding pair is an antibody.

Assignees

Inventors

Classifications

  • involving interaction of two or more labels, e.g. resonant energy transfer · CPC title

  • Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11073512B2 cover?
Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The …
Who is the assignee on this patent?
Enzo Life Sciences Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/53. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).